NFKB1 and Alzheimer disease: Rather, the NF-κB expression increased in the Dermatop and CA treatment groups (AD+Der, AD+CA-80, and AD+CA-200) compared with the AD group (2.0-, 2.1-, and 1.9-fold, respectively).